Serum markers of cardiac fibrosis suffering from heart failure with preserved left ventricular ejection fraction upon ST-segment elevation myocardial infarction

Serum markers of cardiac fibrosis suffering from heart failure with preserved left ventricular ejection fraction upon ST-segment elevation myocardial infarction

Aim. Currently, there is no method which accurately predicts an adverse outcome of heart failure with a preserved left ventricular ejection fraction (HFpEF) upon ST-segment elevation myocardial infarction (STEMI). Here we studied the prognostic significance of procollagen type I C-terminal propeptid...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Оsokina, V. N. Karetnikova, O. M. Polikutina, O. V. Gruzdeva, T. P. Solodilova, S. N. Kosareva, A. V. Motova, T. B. Pecherina, O. L. Barbarash
Format: Article
Language:Russian
Published: Kemerovo State Medical University 2021-09-01
Series:Фундаментальная и клиническая медицина
Subjects:
st-segment elevation myocardial infarction
cardiac fibrosis
heart failure with preserved left ventricular ejection fraction
adverse outcome
Online Access:https://fcm.kemsmu.ru/jour/article/view/436
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://fcm.kemsmu.ru/jour/article/view/436

Similar Items